Product for diagnosis, treatment and prognosis prediction of pancreatic ductal adenocarcinoma and application thereof

The invention belongs to the field of biological medicine, and particularly relates to a product for diagnosis, treatment and prognosis prediction of pancreatic ductal adenocarcinoma and application of the product. The invention discloses lncRNA-PATB1, and diagnosis, treatment and prognosis prediction of pancreatic ductal adenocarcinoma can be realized on the basis of the lncRNA-PATB1. In-depth experiments prove that the lncRNA-PATB1 is related to proliferation, migration and invasion of the adenocarcinoma of the glandular duct, the lncRNA-PATB1 promotes proliferation, migration and invasion of cells of the adenocarcinoma of the pancreatic duct, the lncRNA-PATB1 can be used as a novel treatment target of the adenocarcinoma of the pancreatic duct, and the prognosis condition of the adenocarcinoma of the pancreatic duct can be prompted based on the expression of the gene lncRNA-PATB1. 本发明属于生物医药领域，具体涉及用于胰腺导管腺癌的诊断、治疗和预后预测的产品及其应用。本发明公开了lncRNA-PATB1，基于lncRNA-PATB1能够实现胰腺导管腺癌的诊断、治疗及预后预测。本发明通过深入的实验，证明了lncRNA-PATB1与腺导管